Coronavirus: FDA says it's monitoring market for drug shortages, fraudulent treatment claims

The U.S. Food and Drug Administration said Tuesday the agency is monitoring the market for potential drug shortages and fraudulent treatment claims as the coronavirus outbreak places a pause on its product inspections in China.